Abscis Buy Rating Reiterated at HC Wainwright
ABSI Stock | USD 3.05 0.11 3.74% |
Under 50% of Absci Corp's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Absci Corp suggests that some traders are interested. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
HC Wainwright reiterated their buy rating on shares of Absci in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage currently has a 7.00 target price on the stock. HC Wainwright also issued estimates for Abscis Q4 2024 earnings at EPS, FY2024 earnings at EPS, Q1
Read at thelincolnianonline.com
Absci Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Absci Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Absci Corp is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
XFOR | X4 Pharmaceuticals | 11.43 | ||||
RXRX | Recursion Pharmaceuticals | 10.82 | ||||
SANA | Sana Biotechnology | 9.02 | ||||
HEPA | Hepion Pharmaceuticals | 4.69 | ||||
ELEV | Elevation Oncology | 3.23 | ||||
DTIL | Precision BioSciences | 2.53 | ||||
ZURA | Zura Bio | 1.67 | ||||
DAWN | Day One | 1.53 | ||||
ABOS | Acumen Pharmaceuticals | 0.44 | ||||
INZY | Inozyme Pharma | 0.37 | ||||
CRBU | Caribou Biosciences | 0.45 | ||||
AFMD | Affimed NV | 1.05 | ||||
RLAY | Relay Therapeutics | 2.08 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |